Trials / Conditions / Higher-risk Myelodysplastic Syndromes
Higher-risk Myelodysplastic Syndromes
5 registered clinical trials studyying Higher-risk Myelodysplastic Syndromes — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematolog NCT07155226 | AstraZeneca | Phase 1 / Phase 2 |
| Recruiting | VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS NCT06471946 | Navy General Hospital, Beijing | Phase 1 / Phase 2 |
| Recruiting | Study of REM-422 in Patients With AML or Higher Risk MDS NCT06297941 | Remix Therapeutics | Phase 1 |
| Recruiting | A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes NCT06196203 | Akeso | Phase 2 |
| Terminated | A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02) NCT04417517 | ALX Oncology Inc. | Phase 1 |